Live Breaking News & Updates on Adaptive Biotechnologies

Stay updated with breaking news from Adaptive biotechnologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Adaptive Biotechnologies Q1 Loss decreases, beats estimates

Adaptive Biotechnologies Q1 Loss decreases, beats estimates
rttnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rttnews.com Daily Mail and Mail on Sunday newspapers.

Thomson Reuters , Adaptive Biotechnologies ,

Adaptive Biotechnologies Co. (NASDAQ:ADPT) Given Average Rating of "Moderate Buy" by Brokerages

Adaptive Biotechnologies Co. (NASDAQ:ADPT) Given Average Rating of "Moderate Buy" by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Stacyl Taylor , Goldman Sachs Group , Adaptive Biotechnologies Corporation , Massachusetts Financial Services Co , Jpmorgan Chase Co , Securities Exchange Commission , Investment Management , Adaptive Biotechnologies Company Profile , Adaptive Biotechnologies Co , Adaptive Biotechnologies , Get Free Report , Marketbeat Ratings , Exchange Commission , Capital Management , Massachusetts Financial Services , Financial Services , Get Free , Biotechnologies Corporation , Adaptive Biotechnologies Daily ,

Adaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Sold by Robertson Stephens Wealth Management LLC

Robertson Stephens Wealth Management LLC lessened its stake in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Free Report) by 8.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 183,786 shares of the company’s stock after selling 16,000 shares during the quarter. […] ....

Lewis Asset Management , Securities Exchange Commission , China Universal Asset Management Co , Exchange Commission , Goldman Sachs Group , Savant Capital , Victory Capital Management Inc , Adaptive Biotechnologies Corporation , Jpmorgan Chase Co , Robertson Stephens Wealth Management , Adaptive Biotechnologies Co , Adaptive Biotechnologies , Free Report , Stephens Wealth Management , Universal Asset Management , Capital Management , Get Free Report , Biotechnologies Corporation , Adaptive Biotechnologies Daily , Nasdaq Adpt , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Analysts Set Adaptive Biotechnologies Co. (NASDAQ:ADPT) Target Price at $6.80

Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report) has received a consensus rating of “Moderate Buy” from the six research firms that are currently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year price […] ....

Julie Rubinstein , Stacyl Taylor , Jpmorgan Chase Co , First Trust Direct Indexing , Capital Management Inc , Goldman Sachs Group , Adaptive Biotechnologies Co , Mesirow Financial Investment Management Inc , Adaptive Biotechnologies Corporation , Securities Exchange Commission , Adaptive Biotechnologies , Get Free Report , President Julie Rubinstein , Exchange Commission , Financial Investment Management , Get Free , Biotechnologies Corporation , Adaptive Biotechnologies Daily , Nasdaq Adpt ,

TIM-3+ CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies

TIM-3+ CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies
science.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science.org Daily Mail and Mail on Sunday newspapers.

United States , Lyell Immunopharma , Napajen Pharma , Cellectar Biosciences , Fred Hutch , Bristol Myers Squibb , Seattle Translation Tumor Research , Syndax Pharmaceuticals , Lymphoma Society , Serplus Technology , National Cancer Institute , Specialized Center , Generon Corporation , Research Award , Translational Research Fellowship , American Association For The Advancement Of Science , American Association , Science Journals Default , Klorfine Fellowship , Investigator Award , Scientific Computing Infrastructure , Juno Therapeutics , Adaptive Biotechnologies , Bristol Myers , Seattle Genetics , Janssen Biotech ,